Literature DB >> 14982987

Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.

Zhengfan Jiang1, Tak W Mak, Ganes Sen, Xiaoxia Li.   

Abstract

We have previously shown that double-stranded RNA-triggered, Toll-like receptor 3 (TLR3)-mediated signaling is independent of MyD88, IRAK4, and IRAK. Instead, TRAF6, TAK1, and TAB2 are recruited to TLR3 on poly(I.C) stimulation. TRAF6-TAK1-TAB2 are then translocated to the cytosol where TAK1 is phosphorylated and activated, leading to the activation of IkappaB kinase and NFkappaB. The present study addressed two important questions: (i) How are TRAF6, TAK1, and TAB2 recruited to TLR3? (ii) Are TRAF6, TAK1, and TAB2 also required for TLR3-mediated IRF3 activation? Recently, a novel Toll-IL-1 receptor (TIR)-containing adapter, TIR domain-containing adapter inducing IFN-beta (TRIF), was shown to play a critical role in TLR3-mediated activation of NF-kappaB and IRF3. We found that TLR3 recruits TRAF6 via adapter TRIF through a TRAF6-binding sequence in TRIF (PEEMSW, amino acids 250-255). Mutation of this TRAF6-binding sequence abolished the interaction of TRIF with TRAF6, but not with TLR3. Interestingly, mutation of the TRAF6-binding site of TRIF only abolished its ability to activate NF-kappaB but not IRF3, suggesting that TLR3-mediated activation of NF-kappaB and IRF3 might bifurcate at TRIF. In support of this finding, we showed that DN-TRAF6 and DN-TAK1 blocked poly(I.C)-induced NF-kappaB but not IRF3 activation. Furthermore, whereas poly(I.C)-induced NF-kappaB activation is completely abolished inTRAF6-/- MEFs, the signal-induced activation of IRF3 is TRAF6 independent. In conclusion, TRIF recruits TRAF6-TAK1-TAB2 to TLR3 through its TRAF6-binding site, which is required for NF-kappaB but not IRF3 activation. Therefore, double-stranded RNA-induced TLR3/TRIF-mediated NF-kappaB and IRF3 activation diverge at TRIF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982987      PMCID: PMC373497          DOI: 10.1073/pnas.0308496101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.

Authors:  Marion Jurk; Florian Heil; Jörg Vollmer; Christian Schetter; Arthur M Krieg; Hermann Wagner; Grayson Lipford; Stefan Bauer
Journal:  Nat Immunol       Date:  2002-06       Impact factor: 25.606

2.  IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase.

Authors:  Shyun Li; Astrid Strelow; Elizabeth J Fontana; Holger Wesche
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.

Authors:  Zhengfan Jiang; Jun Ninomiya-Tsuji; Youcun Qian; Kunihiro Matsumoto; Xiaoxia Li
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

4.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.

Authors:  F Hayashi; K D Smith; A Ozinsky; T R Hawn; E C Yi; D R Goodlett; J K Eng; S Akira; D M Underhill; A Aderem
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

5.  Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Osamu Takeuchi; Shintaro Sato; Hideki Sanjo; Katsuaki Hoshino; Takao Horiuchi; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

6.  Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.

Authors:  Nobutaka Suzuki; Shinobu Suzuki; Gordon S Duncan; Douglas G Millar; Teiji Wada; Christine Mirtsos; Hidetoshi Takada; Andrew Wakeham; Annick Itie; Shyun Li; Josef M Penninger; Holger Wesche; Pamela S Ohashi; Tak W Mak; Wen-Chen Yeh
Journal:  Nature       Date:  2002-03-31       Impact factor: 49.962

7.  IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK).

Authors:  X Li; M Commane; Z Jiang; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

8.  Distinct molecular mechanism for initiating TRAF6 signalling.

Authors:  Hong Ye; Joseph R Arron; Betty Lamothe; Maurizio Cirilli; Takashi Kobayashi; Nirupama K Shevde; Deena Segal; Oki K Dzivenu; Masha Vologodskaia; Mijung Yim; Khoi Du; Sujay Singh; J Wesley Pike; Bryant G Darnay; Yongwon Choi; Hao Wu
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

9.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

10.  Double-stranded RNA signaling by Toll-like receptor 3 requires specific tyrosine residues in its cytoplasmic domain.

Authors:  Saumendra N Sarkar; Heather L Smith; Theresa M Rowe; Ganes C Sen
Journal:  J Biol Chem       Date:  2002-12-30       Impact factor: 5.157

View more
  137 in total

1.  Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation.

Authors:  Maninjay K Atianand; Ellen B Duffy; Aaloki Shah; Supriya Kar; Meenakshi Malik; Jonathan A Harton
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

Review 2.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

3.  Murine adult neural progenitor cells alter their proliferative behavior and gene expression after the activation of Toll-like-receptor 3.

Authors:  A Melnik; S Tauber; C Dumrese; O Ullrich; S A Wolf
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

4.  Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells.

Authors:  Kai Yang; Hexin Shi; Rong Qi; Shaogang Sun; Yujie Tang; Bianhong Zhang; Chen Wang
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

Review 5.  New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.

Authors:  Monica Ruse; Ulla G Knaus
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

Authors:  Serena Ghisletti; Wendy Huang; Sumito Ogawa; Gabriel Pascual; Mu-En Lin; Timothy M Willson; Michael G Rosenfeld; Christopher K Glass
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

7.  Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation.

Authors:  Kenji Funami; Miwa Sasai; Hiroyuki Oshiumi; Tsukasa Seya; Misako Matsumoto
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

8.  Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo.

Authors:  Dana M Bronte-Tinkew; Mauricio Terebiznik; Aime Franco; Michelle Ang; Diane Ahn; Hitomi Mimuro; Chihiro Sasakawa; Mark J Ropeleski; Richard M Peek; Nicola L Jones
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  Pyogenic bacterial infections in humans with MyD88 deficiency.

Authors:  Horst von Bernuth; Capucine Picard; Zhongbo Jin; Rungnapa Pankla; Hui Xiao; Cheng-Lung Ku; Maya Chrabieh; Imen Ben Mustapha; Pegah Ghandil; Yildiz Camcioglu; Júlia Vasconcelos; Nicolas Sirvent; Margarida Guedes; Artur Bonito Vitor; María José Herrero-Mata; Juan Ignacio Aróstegui; Carlos Rodrigo; Laia Alsina; Estibaliz Ruiz-Ortiz; Manel Juan; Claudia Fortuny; Jordi Yagüe; Jordi Antón; Mariona Pascal; Huey-Hsuan Chang; Lucile Janniere; Yoann Rose; Ben-Zion Garty; Helen Chapel; Andrew Issekutz; László Maródi; Carlos Rodriguez-Gallego; Jacques Banchereau; Laurent Abel; Xiaoxia Li; Damien Chaussabel; Anne Puel; Jean-Laurent Casanova
Journal:  Science       Date:  2008-08-01       Impact factor: 47.728

10.  TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells.

Authors:  Diana M Lim; Sneha Narasimhan; Carmen Z Michaylira; Mei-Lun Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.